Observational studyPloS one2025

Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance.

Akie Yoshinaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.